The FDA has approved VIZZ, the first aceclidine-based eye drop designed to restore near vision for up to 10 hours, offering ...
Targeting Tear Function for Sustained Relief” convenes leading experts in ophthalmology and optometry to discuss evolving ...
Targeting Tear Function for Sustained Relief” convenes leading experts in ophthalmology and optometry to discuss evolving ...
Zhaoke Ophthalmology Ltd. ( ($HK:6622) ) has shared an announcement. Zhaoke Ophthalmology Limited announced the approval of its Investigational ...